Evidence map›Paper›PMID 41061865›Full record

ArticleGastroenterology2026

Mass Screening of Celiac Disease: A Crossing Point Between Secondary and Primary Prevention?

Marisa G Stahl, Maureen M Leonard, Edwin Liu, Maria Ines Pinto-Sanchez, Gideon Lack, Carlo Catassi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marisa G StahlColorado Center for Celiac Disease, Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Maureen M LeonardCenter for Celiac Research and Treatment, Division of Pediatric Gastroenterology and Nutrition, Mass General Brigham for Children, Harvard Medical School, Boston, Massachusetts.
Edwin LiuColorado Center for Celiac Disease, Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Maria Ines Pinto-SanchezFarncombe Family Digestive Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Gideon LackPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences; Paediatric Allergy Group, Department of Women and Children's Health, School of Life Course and Population Sciences, King's College London; Children's Allergy Service, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Carlo CatassiCenter for Celiac Disease and Treatment, Division of Pediatric Gastroenterology and Nutrition, Mass General Brigham for Children, Harvard Medical School, Boston, Massachusetts; Department of Pediatrics, Polytechnic University of Marche, Ancona, Italy.

Funding

Prospective Multi-Omic Analysis of At-Risk infants to Model Celiac Disease PathogenesisK23DK122127 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LEONARD, MAUREEN MICHELLE · 2019 to 2023
$1.2M
NIDDK NIH HHS K23 DK122127
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41061865
PMCPMC13112529

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.